About 455,000 results
Open links in new tab
  1. HRD vs. BRCA - same or different? - Ovarian Cancer Community

    The BRCA mutation is an HRD mutation (homologous recombination deficiency mutation) - it is the most common HRD mutation. You can be HRD positive and BRCA negative. Studies have demonstrated …

  2. Anyone long-term survivor without maintenance therapy?

    Sep 24, 2025 · Not as easy to get a parp after recurrence anymore, especially for BRCA negative/HRD negative. My doctor convinced me to try a parp despite minimal expected benefit for women like me. …

  3. How do I know if my mom is HRD+ - Ovarian Cancer Community

    May 29, 2021 · When I was diagnosed in 2017, the recommendation was for every woman diagnosed with ovarian cancer to have genetic testing for BRCA mutations. If you have the inherited mutation, …

  4. Free Webinar Series: Testing for HRD in Cancer

    Sep 17, 2024 · FYI, a 3 part series on Homologous Recombination Deficiency testing in cancer care. Sponsored by the Association for Molecular Pathology in

  5. Does insurance cover HRD testing? - Ovarian Cancer Community - Inspire

    Will Insurance cover HRD testing? I am on Medicare and have a good supplemental;

  6. HRD vs. BRCA - same or different? - Ovarian Cancer Community

    Mar 24, 2020 · My Mom just had her debulking surgery in January and sample tumor tissue was sent for genetic testing. My understanding is that she tested negative for the BRCA mutation but that an HRD …

  7. Avastin + Rubraca - Ovarian Cancer Community - Inspire

    Jun 10, 2020 · I'm HGSOC, BRCA negative & HRD negative but HRD testing today is still in it's infancy and can be very inaccurate. I have some mutations that my onc still suspects makes me HRD …

  8. General thoughts on the tools oncologist have in their toolbox ...

    Sep 30, 2025 · Testing is done on tumor tissue to confirm HER2 status. Disease Stage: Unresectable (cannot be surgically removed) or metastatic (spread to other parts of the body) ovarian cancer. Prior …

  9. Stage 4A - Chances of recurrence - Ovarian Cancer Community

    Feb 18, 2024 · Even viable tissue for HRD testing was not available. That's a very good prognostic marker as it shows that the tumor was highly platinum sensitive. The other important point is that an …

  10. Who does tumor testing for Parp Inhibitors? - Inspire

    Jun 26, 2019 · Unfortunately, I didn't know to ask at the time, but found out their testing doesn't include sensitivity to Parp Inhibitors based on HRD (Homologous Recombination Deficiency) only BRCA …